Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study.
| Image |  |
|---|---|
| Description | scientific article published on 14 March 2017 |
| Author/s |
author: Hisashi Yamanaka Tsutomu Takeuchi |
| Publication date | March 14, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |